retatrutide type 2 diabetes phase 2 results 2024 Effects of on body composition in people with diabetes: a substudy of a 2, double-blind, parallel-group, placebo-controlled, randomised trial The Science Behind Retatrutide: A

Rodriguez PJ et al

Tregellas International Journal of Obesity.2026;[Epub] CrossRef Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance Raynier Zambrano-Villacres, Martn Campuzano-Donoso, Claudia Reytor-Gonzlez, Gianluca Rossetti, Luigi Cobellis, Francesco Cobellis, Vincenzo Pilone, Daniel Simancas-Racines, Luigi Schiavo Nutrients.2026

Side effects often peak during this period, particularly in weeks 2-4 as doses increase

Most incretin-based compounds target only the first two the addition of glucagon receptor agonism distinguishes this compound in research settings